Literature DB >> 3110271

rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.

M H Ben Aribia, E Leroy, O Lantz, D Métivier, B Autran, B Charpentier, T Hercend, A Senik.   

Abstract

Cells participating in the rIL 2-induced proliferation of resting PBMC were identified by using different methods of cell purification. NK cells recovered in the light density fraction of Percoll gradients responded, as already known, directly to rIL 2 by strong proliferation. In contrast, large T lymphocytes co-purifying with NK cells, and small T cells sedimenting in the high density area of the Percoll gradients, were virtually unresponsive when cultivated in the sole presence of rIL 2. However, the addition of either irradiated autologous monocytes or highly purified IL 1 allowed both kinds of T cells to undergo cell division. Stringent elimination of possibly contaminating NK cells (NKH-1+) and/or activated T cells (TNKTAR, Tac+, HLA-DR+) from the high density T cells by complement lysis did not impair rIL 2-induced cell proliferation, indicating entire responsiveness of these cells to the synergistic action of IL 1 plus IL 2. Both high density CD4+ and CD8+ participated in this phenomenon, with an apparent advantage for CD4+ cells. All Tac+ cells emerging in a 6-day culture of these cells expressed the WT31 antigen, which indicates that T cells involved in rIL 2-induced proliferation are conventional mature T cells. The relative precursor frequencies of NK cells, large T lymphocytes, and small T lymphocytes that proliferated in response to rIL 2 were analyzed by limiting dilution analysis. The frequencies of clonal growth of NK cells and low density T lymphocytes were approximately the same (1/103 vs 1/185), whereas that of high density T cells was four times lower (1/458). Thus, we clearly demonstrate that resting T cells, defined as such by morphological, density, and phenotypic criteria, are able to proliferate in response to IL 2 in the presence of IL 1 without antigenic or mitogenic triggering.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Recombinant human interleukin-2-induced mitogenic proliferation of in vitro unstimulated bovine intestinal lymphocytes.

Authors:  A M Nagi; L A Babiuk
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

2.  Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

3.  Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells.

Authors:  E Sitnicka; M Hansson
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.

Authors:  F Denis; D Archambault
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

5.  Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity.

Authors:  E Katsanis; D J Weisdorf; Z Xu; B B Dancisak; M L Halet; B R Blazar
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

6.  Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype.

Authors:  U Testa; A Care; E Montesoro; C Fossati; G Giannella; R Masciulli; M Fagioli; D Bulgarini; D Habetswallner; G Isacchi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.

Authors:  P Conti; R A Dempsey; M Reale; R C Barbacane; M R Panara; M Bongrazio; J W Mier
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

8.  Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.

Authors:  Jie Liu; Xiao Yang; Liang Zhang; Bo Yang; Wen Rao; Mengxia Li; Nan Dai; Yuxin Yang; Chengyuan Qian; Lei Zhang; Hualiang Xiao; Dong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2020-06-18       Impact factor: 4.553

9.  A model for cancer-suppressive inflammation.

Authors:  Ole Audun Werner Haabeth; Bjarne Bogen; Alexandre Corthay
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

10.  Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells.

Authors:  Y Nakamura; T Nishimura; Y Tokuda; N Kobayashi; K Watanabe; T Noto; T Mitomi; K Sugamura; S Habu
Journal:  Jpn J Cancer Res       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.